Veno Arterial ECMO System Market Report

Market Insights

The Veno-Arterial ECMO System market is projected to grow from USD 262.3 million in 2020 to USD 326.5 million by 2026 at a CAGR of around 3.8% during the forecast period.

Figure: Veno-Arterial ECMO System Market Size, 2020-2026 (USD Million)

Wish to get a free sample? Register Here

What is veno-arterial ECMO system?

Veno-arterial extracorporeal membrane oxygenation (ECMO) also referred to as extracorporeal life support will be defined as a type of temporary mechanical circulatory support and simultaneous extracorporeal gas exchange. It's emerged as a salvage intervention in patients with cardiogenic shock, even cardiopulmonary arrest refractory to plain therapies.

Key Players

Key players operating in the Veno-Arterial ECMO System market are-

• Sorin Group (Italy)
• Medtronic plc (Ireland)
• MAQUET Holding B.V. & Co. KG (Germany)
• Terumo Corporation (Japan)
• Xenios AG (Germany)
• Nipro Corporation (Japan)
• MicroPort (China)
• CORMED Medizintechnik GmbH & Co. KG (Germany)
• Medos Medizintechnik AG (Germany)
• LivaNova, PLC (UK)
• CytoSorbents Corporation (US).

Market Dynamics

The growth of Veno-Arterial ECMO System market is primarily driven by rising incidences of pulmonary diseases and cardiac arrest. Increasing prevalence of heart related diseases due to stress and unhealthy eating habits is likely to propel the market growth at a significant rate during the review period. In addition to this, rising demand for technologically advanced veno-arterial ECMO system is likely to create lucrative opportunities for the players operating in the global market in the coming years.

Segment Analysis

Application Trends

By application, the veno-arterial ECMO system market has been bifurcated into neonatal, pediatric and adult. Under these, the adult segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period.

Regional Trends

By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The regional growth can be attributed to high product adoption rate and presence of key market players such as CytoSorbents Corporation (US). The market growth in Asia-Pacific region is expected to be driven by rising number of patients having pulmonary or cardiovascular diseases.

COVID-19 Impact on Veno-Arterial ECMO System Market

The covid-19 outbreak posed significant challenges on the various verticals across geographies. It impacted the growth of the veno-arterial ECMO system market negatively for a short period of time as imposition of complete lockdown and restrictions on trade affected the product supply.

Critical Questions Answered in the Report

• What are the key trends in the Veno-Arterial ECMO System market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in next five years?
• What is the impact of COVID-19 on Veno-Arterial ECMO System market?
• What are the key strategies adopted by the major vendors to lead in the Veno-Arterial ECMO System market?
• What is the market share of the top vendors?

Get the full scope of the report. Register Here

Target Audience

Here is the list of the group of customers that the veno-arterial ECMO system market hopes to have the greatest opportunity to convert-

• Veno-arterial ECMO system distributors
• Veno-arterial ECMO system suppliers
• Veno-arterial ECMO system manufacturers
• Logistics organizations
• Government bodies

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].